Dynamic Bitcoin Artwork Debuts at Christie’s Auctionby John Darbie 30.09.2024Christie's to auction 'Ascend,' a dynamic Bitcoin Ordinal artwork, showcasing innovative digital art on blockchain.
Nvidia’s Portfolio Stocks Face Q2 Challengesby Mark Eisenberg 17.08.2024Nvidia's stock holdings faced declines in Q2, but most have gained since early 2024, outpacing S&P 500 growth.
AI Predicted to Boost Returns in Biotech Stocksby Lilu Anderson 13.08.2024AI integration in biotech could reduce R&D costs, enhance efficiency, and increase returns for investors.
Recursion Merges with Exscientia to Accelerate Drug Discoveryby Lilu Anderson 13.08.2024Recursion Pharmaceuticals merges with Exscientia to revolutionize drug discovery, bringing new treatments to market more quickly.
Recursion to Acquire Exscientia for $688M in AI-Powered Dealby Mark Eisenberg 09.08.2024Recursion Pharmaceuticals acquires Exscientia to enhance AI drug discovery, potentially saving millions in drug development costs.
Exscientia and Recursion Merge to Form AI Drug Discovery Giantby Lilu Anderson 08.08.2024Exscientia merges into Recursion to form a $850 million AI drug discovery powerhouse, focusing on oncology and rare diseases.